Alnylam Pharmaceuticals
ALNY
#618
Rank
HK$252.55 B
Marketcap
HK$1,951
Share price
3.69%
Change (1 day)
73.46%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company